 CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 16, 2020 GLOBE NEWSWIRE -- Centogene N.V. Nasdaq: CNTG CENTOGENE or the Company, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today provided an update on its corporate progress and reported its financial results for the three and nine months ended September 30, 2020. 